Dalpiciclib 125mg Clinical Trials

2 actively recruiting trials

▲ +1 trial since May 2026

Pipeline

Phase 2: 2

Top Sponsors

wanghaibo1
Fujian Cancer Hospital1

Indications

Breast Cancer2
Cancer2
Endocrine Breast Diseases1
Dalpiciclib1
CDK4/6 Inhibitor1

Other2 trials

Different Doses of Dalpicicl Combined With Letrozole in the First-line Treatment of HR-positive, HER2-negative Advanced Breast Cancer

Phase 2

Efficacy and Safety of Dalpiciclib Combined With Endocrine Adjuvant Therapy for Early HR +/HER2- Breast Cancer: a Multicenter, Prospective Clinical Study

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.